Development and validation of an HPLC-DAD analytical method for psilocybin and psilocin
Science Letters · 04.05.2025
DOI: 10.48797/sl.2025.330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Letters, erschienen am 04.05.2025. Verfasst von Beatriz P. Senra und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background: "Magic mushrooms", also known as hallucinogenic mushrooms, belong to the genus Psilocybe and contain tryptamines, especially psilocybin and psilocin, with potential medicinal benefits for mental health [1]. Psilocybin is usually found in higher concentrations than psilocin and both are present in dried mushrooms at a total concentration of approximately 0.5 to 1.5%. Psilocybe mushrooms are used for religious, recreational, and therapeutic purposes due to their psychedelic effects [1]. The increasing use of these tryptamines and other psychoactive drugs led to regulatory legislation, specifically Portuguese Decree-Law No. 15/93 of January 22, which aims to control the production, distribution, possession, and use of these substances. High-performance liquid chromatography (HPLC) coupled with UV-Vis, diode array (DAD) [2], or mass spectrometry (MS) [3] are commonly used analytical methods to quantify tryptamines.
Objective
Development and validation of an HPLC-DAD analytical method for quantification of psilocybin and psilocin in Psilocybe cubensis extracts.
Methods
Mushrooms were pulverised using a porcelain mortar and pestle and extracted with cold methanol by kinetic maceration on a magnetic stirrer plate. An Agilent 1260 Infinity II HPLC-DAD system with a Poroshell 120 EC-C18 3.0 x 150 mm, 2.7 µm column protected with a Poroshell 120 EC-C18 3.0 mm, 2.7 µm guard column was used for analytical determinations. The optimised chromatographic method was established with mobile phase solvents: 10 mM ammonium formate with 0.1% formic acid and acetonitrile; oven temperature: 40 °C; flow rate: 0.8 mL/min; total run time: 12 minutes; injection volume: 1 µL; and UV detection wavelength: 220 nm.
Results
To optimise the HPLC-DAD analytical method, various parameters were evaluated: mobile phase gradients and solvents, oven temperature, flow rate, run time, post-run time, injection volume and UV detection wavelength. This analytical procedure was validated following the ICH Q2 guideline. Linearity was tested over a range of 9 concentrations (0.50-200 µg/mL for psilocybin and 0.25-100 µg/mL for psilocin), obtaining R2 values > 0.999. Method precision (%RSD) was £ 10%, with an accuracy (%bias) £ 15% for both compounds.
Conclusions
An HPLC-DAD analytical method for the detection and quantification of psilocybin and psilocin was optimised, validated, and effectively applied to Psilocybe cubensis extracts.
Schlagwörter
Zitieren
APA
Senra, B. P., Bartholomaeus, J. H., Dinis‐Oliveira, R. J., & Ribeiro, C. J. A. (2025). Development and validation of an HPLC-DAD analytical method for psilocybin and psilocin. Science Letters. https://doi.org/10.48797/sl.2025.330
Vancouver
Senra BP, Bartholomaeus JH, Dinis‐Oliveira RJ, Ribeiro CJA. Development and validation of an HPLC-DAD analytical method for psilocybin and psilocin. Science Letters. 2025. doi:10.48797/sl.2025.330
BibTeX
@article{Senra2025,
author = {Senra, Beatriz P. and Bartholomaeus, Johannes H and Dinis‐Oliveira, Ricardo Jorge and Ribeiro, Carlos J. A.},
title = {Development and validation of an HPLC-DAD analytical method for psilocybin and psilocin},
journal = {Science Letters},
year = {2025},
doi = {10.48797/sl.2025.330}
}
EUVIMED